The TGA has issued the Aug
edition of its Medicines Safety
Update, with topics including
vancomycin and nephrotoxicity,
dexmedetomidine hydrochloride
and cardiovascular events, as well
as bevacizumab and necrotising
fascitis.
Also covered is dapagliflozin, the
first SGLT2 (selective and reversible
inhibitor of the sodium-glucose cotransporter
2) - a new class of drugs
indicated for the treatment of type
2 diabetes.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Aug 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Aug 13
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.